Calcium concentration in hypoxic-ischemic encephalopathy during hypothermia

Area of Science:

• Neonatal Neurology
• Neurocritical Care
• Biochemistry

Background:

• Hypoxic-ischemic encephalopathy (HIE) is a major cause of neonatal brain injury.
• Brain hypothermia (BHT) is a standard treatment for HIE.
• The role of serum-ionized calcium in HIE prognosis during BHT is not fully understood.

Purpose of the Study:

• To investigate the relationship between serum-ionized calcium levels and neurological prognosis in HIE neonates undergoing BHT.
• To analyze changes in serum-ionized calcium before and during BHT.

Main Methods:

• Serum samples were collected from 16 neonates with HIE treated with BHT.
• Developmental testing was performed at 18 months of age to assess outcomes.
• Serum-ionized calcium concentrations were measured before and during BHT.

Main Results:

• Neonates with poor outcomes (Developmental Quotient [DQ] <80) had significantly lower serum-ionized calcium levels than those with good outcomes (DQ >80).
• Serum-ionized calcium levels decreased significantly in both groups during 6 hours of BHT.
• A lowest adjusted serum-ionized calcium concentration below 1.05 mmol/L, a known poor outcome indicator, was observed in 57.1% of the good outcome group.

Conclusions:

• Calcium influx into cells continues during early BHT, irrespective of neurological prognosis.
• BHT may offer neuroprotection against neurological damage in high-risk neonates even with low serum-ionized calcium concentrations.